← Back to Search

Transgender and Gender-Diverse Persons for Breast Cancer

N/A
Recruiting
Led By Chandler S Cortina, MD, MS
Research Sponsored by Medical College of Wisconsin
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 3.5 years
Awards & highlights

Study Summary

This investigation is a prospective breast cancer screening study open to all transgender and gender-diverse persons (regardless of sex assigned at birth). Using a mixed methods approach, the study will 1) gather prospective quantitative breast imaging data in conjunction with gender-affirming therapy and family cancer history and 2) investigate TGD persons perceptions and experiences in the breast cancer screening program, and 3) identify individual and systems-level barriers to breast cancer screening.

Eligible Conditions
  • Breast Cancer

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~3.5 years
This trial's timeline: 3 weeks for screening, Varies for treatment, and 3.5 years for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Callback and Biopsy Rates after Breast Cancer Screening
Reflexive Thematic Analysis of the Physical, Cognitive, and Emotional Experience of Breast Cancer Screening in Transgender and Gender Diverse Persons
Reflexive Thematic Analysis on the Individual & System-Level Barriers to Breast Cancer Screening

Trial Design

2Treatment groups
Experimental Treatment
Group I: Transgender and Gender-Diverse PersonsExperimental Treatment2 Interventions
Breast imaging data in the form of standard screening mammography in addition to screening whole breast ultrasound will be gathered and interpretations will follow the standard Breast Imaging Reporting and Data Systems. Insight on the perceptions and experiences of being involved in a breast cancer screening program will be gathered.
Group II: Breast Imaging StakeholdersExperimental Treatment1 Intervention
A semi-structure focus group to explore radiology faculty and staff experiences while capturing information on the perceived screening barriers, what support and/or training staff require to ensure patients are treated equitable in the screening process, and areas for providers and healthcare systems to improve breast cancer screening for transgendered and nonbinary persons.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Breast Cancer Screening
2013
N/A
~240

Find a Location

Who is running the clinical trial?

Medical College of WisconsinLead Sponsor
610 Previous Clinical Trials
1,162,583 Total Patients Enrolled
14 Trials studying Breast Cancer
409,343 Patients Enrolled for Breast Cancer
Chandler S Cortina, MD, MSPrincipal InvestigatorThe Medical College of Wisconsin

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
clinicaltrials.govStudy
Transgender and Gender-Diverse Breast Cancer Screening Pilot
Chandler S Cortina 2024. "Transgender and Gender-Diverse Breast Cancer Screening Pilot". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT06383026.
All > Chicago > Milwaukee
~87 spots leftby Dec 2027
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top